Jump to start of content

Complete your MOC requirements by 12/31/24 to avoid a change in certification status Expand/Collapse the ABIM alert.

Sign in to your Physician Portal to view any remaining requirements for the year. Not completing these requirements by 12/31/24 could result in a change to “Not Certified” for one or more certificates.

Expand All | Collapse All

Erin Bonura, MD, Chair

Erin Bonura

Dr. Bonura received her medical degree from Georgetown University in 2006. Following medical school, she completed her internship and residency at the Hospital of the University of Pennsylvania and New York University where she became board certified in Internal Medicine and was also named Chief Resident. Subsequently, Dr. Bonura continued her postgraduate training at Oregon Health & Science University (OHSU) and attained board certification in Infectious Diseases.

Given her passion for medical education she completed a second fellowship at OHSU in General Internal Medicine and completed her Master's degree in Clinical Research with a focus on medical education methods and outcomes in the undergraduate and graduate settings. In addition to her scholarship, Dr. Bonura has taken on a number of education leadership roles at OHSU including Thread Director of Microbiology & Immunology for Undergraduate Medical Education (UME) and Program Director for the Infectious Diseases Fellowship Program.

She is also one of the founding members of the Educators' Collaborative which brings together faculty from all schools at OHSU (Medicine, Dentistry, Pharmacy, Nursing, & Public Health) dedicated to education and furthering this mission at OHSU. In 2019 she became a co-director for the Education Scholars Program, a yearlongjh course dedicated to training the next generation of scholars in health sciences education.

As of May 2024, Dr. Bonura reported the following external relationships:

Dr. Bonura serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • The Infectious Diseases Society of America, Board of Directors, without compensation

Dr. Bonura also reported that she serves on the National Board of Medical Examiners infectious disease item-writing committee.

Wendy Armstrong, MD

Wendy Armstrong, MDAfter six years at the Cleveland Clinic, Dr. Armstrong joined the infectious disease faculty at Emory University in 2007 assuming the role of Program Director of the Infectious Disease Fellowship Program in 2008, the Medical Director of the Ponce de Leon Center at Grady Health System in 2009 and was named Vice Chair of Education and Integration for the Department of Medicine in 2014. Dr. Armstrong is currently a Professor of Medicine in the Division of Infectious Disease at the Emory University School of Medicine. She is board certified in Internal Medicine and Infectious Disease. Dr. Armstrong is a member of the American Board of Internal Medicine Infectious Disease Board.

Her research interests in HIV include studying disparities in care for vulnerable patients living with HIV as well as developing innovative approaches to improving the HIV continuum of care. In addition to her role as Medical Director of the Ponce Center, one of the largest HIV clinics in the country, she is the former Chair of the HIV Medicine Association and has been active in advocacy efforts locally, regionally and nationally. She is also active in medical education at all levels of learner. In addition to her leadership role in the fellowship program, she is involved with medical student education both as a Small Group Advisor in the Semmelweis Society and as director of the Infectious Diseases Module in the preclinical years.

Dr. Armstrong received her medical degree from Harvard Medical School in 1994. She completed her internal medicine internship, residency, chief residency and infectious diseases fellowship at the University of Michigan.

As of July 2023, Dr. Armstrong reported the following external relationships:

Dr. Armstrong serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • The Centers for Disease Control and Prevention/Health Resources and Services Administration, Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment, member, receiving honoraria
  • The Infectious Diseases Society of America, board member, receiving reimbursement for travel expenses
  • The Massachusetts Medical Society, receiving compensation for New England Journal of Medicine Journal Watch summaries
  • The National Institutes of Health, Data and Safety Monitoring Board, member, receiving honoraria

Andrea Caballero, MD

Dr. Andrea Caballero is the Medical Director of Infection Prevention and Antimicrobial Stewardship at St. Elias Specialty Hospital (Providence Health System) and a consultant at Providence Alaska Medical Center; she also treats infectious diseases at her private practice in Anchorage. Dr. Caballero is the Head of Denali College at the University of Washington School of Medicine WWAMI Program, the Alaska based student mentorship program, and co-Lead of the Foundations of Clinical Medicine course. She is board certified in Internal Medicine and Infectious Disease.

Previously, Dr. Caballero worked at a critical care access hospital in a small Alaskan community, collaborating with the local health department and providing both inpatient and outpatient consultation in infectious diseases along with primary care services. As Physician Lead of the Infection Prevention and Antimicrobial Stewardship committees, she helped bolster and expand both programs.

As one of just a few infectious disease specialists in Alaska during the COVID-19 pandemic, Dr. Caballero was an integral part of developing infection prevention and treatment guidelines for the local hospitals and providing expert advice to medical providers around the state.

Prior to medical school, Dr. Caballero worked as a Spanish-language medical interpreter and community outreach advocate and educator in post-Katrina New Orleans. She completed her medical education and internal medicine residency at Louisiana State University Health Sciences Center New Orleans and her infectious disease fellowship at Oregon Health and Sciences University.

As of March 2024, Dr. Caballero reported the following external relationships:

Dr. Caballero is the Medical Director of Infection Prevention at St. Elias Specialty Hospital in Anchorage, Alaska. She also covers telemedicine shifts for Eagle Telemedicine a few times per month.

Jorgelina T. de Sanctis, MD, FACP, FIDSA

Jorgelina DeSanctis

Dr. de Sanctis is board certified in Internal Medicine and Infectious Disease. Currently, she is the Program Director of the Infectious Disease Fellowship at Spectrum Health/MSU program in Grand Rapids Michigan.

Previously, Dr. de Sanctis served as Associate Hospital Epidemiologist and staff member of the Infectious disease Division at William Beaumont Hospital in Royal Oak, Michigan. She also served as Associate Staff at the Infectious Disease Department of Cleveland Clinic.

Her research and clinical interest are transplant infectious disease, neuro infectious disease, cardiovascular and device infectious disease and bone and joint infections.

Dr. de Sanctis earned her medical degree from Universidad Nacional de Rosario, Argentina, and an HIV/AIDS master's degree from Universidad de Barcelona in Spain. She completed her internal medicine residency at Hospital Provincial de Rosario in Argentina and the Grand Rapids Medical Education and Research Center/MSU in Grand Rapids, Michigan. She completed her infectious disease fellowship at William Beaumont Hospital.

As of May 2024, Dr. de Sanctis reported no external relationships.

Sasha Gbedemah, MSN, RN

Sasha Gbedemah

Ms. Gbedemah is an Infection Prevention Program Manager for Texas Health Harris Methodist -Hurst-Euless-Bedford (HEB). Her current role at Texas Health HEB includes overseeing the Infection Prevention Program in the acute care hospital setting, as well as a standalone Inpatient Behavioral Hospital, and an additional five satellite behavioral health campuses. She also serves as an Infection Prevention consultant for the Agency for Healthcare Research Quality ECHO National Nursing Home COVID-19 Action Network. Prior to her current position in Infection Prevention and Control she worked as a critical care nurse in various nursing specialties. She is board certified by the Certification Board of Infection Control and Epidemiology.

She serves on the Board for the Association for Professionals in Infection Control and Epidemiology - Dallas-Fort-Worth Chapter. Prior to her current role as Board Member, she was Conference Chair for two consecutive years.

Ms. Gbedemah' s interest in infectious disease and epidemiology is ongoing in her current practice. She recently was awarded Frontline Worker of the Year from the Colleyville Chamber of Commerce for all the efforts she put forth during the COVID-19 pandemic for the hospital and the community. She has acquired international experience after completion of a preceptorship in Ghana, West Africa at Korle-Bu Hospital, the largest teaching hospital in the country.

Ms. Gbedemah received her bachelor of arts degree in biology at University of North Texas in Denton, Texas. She earned her bachelor of science degree in nursing at Midwestern State University and a master of science in nursing informatics at Walden University.

As of July 2024, Ms. Gbedemah reported no ongoing external relationships.

Jesse Milan, Jr., JD

Jesse Milan, Jr., JD

Mr. Milan is a recognized national and global expert and advocate on HIV and is living with HIV for four decades. He is President & CEO of AIDS United a national organization focused on HIV policy, grantmaking, and capacity building. AIDS United has granted over $129 Million and its grantees and Public Policy Council organizations number over 200 in 40 states and territories.

Mr. Milan is a lawyer whose career includes leading HIV programs and organizations at national, regional, and global levels. He has addressed millions across the U.S. and Africa in keynotes, presentations, and sermons. He is currently chair of the board of Funders Concerned About AIDS (FCAA) and serves on the Presidential Advisory Council on HIV/AIDS (PACHA), and on the Scientific Advisory Board for PEPFAR (President’s Emergency Plans for AIDS Relief). He served previously as AIDS Director for Philadelphia, was vice president for 15 years at two federal public health contractor firms and was co-chair of the CDC/HRSA Advisory Committee on HIV and STD (CHAC). He is past board chair of the Black AIDS Institute and the National Episcopal AIDS Coalition and served six years as Chief of Staff to the president of Temple University. His many honors for his work in HIV include from the American Bar Association, HRSA, POZ magazine, and the Association of Nurses in AIDS Care; and an honorary doctorate of Humane Letters from the Virginia Theological Seminary, and the Distinguished Alumni Award from the Association of Black Princeton Alumni.

Mr. Milan is a graduate of Princeton University and the New York Univeristy School of Law.

As of March 2024, Mr. Milan reported the following external relationships:

Mr. Milan serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • AIDS United, President and Chief Executive Officer, receiving salary
  • AIDS Vaccine Advocacy Coalition, without compensation
  • Emory University, serving on advisory councils, without compensation
  • Funders Concerned About AIDS, without compensation
  • The University of North Carolina, Gillings School of Public Health, without compensation

Mr. Milan also serves on the scientific advisory board for the President’s Emergency Plan for AIDS Relief and the Presidential Advisory Council on HIV/AIDS. He also received honoraria from the University of Washington for speaking at the Mountain AIDS Education & Training Centers regional conference.

Raghavendra Tirupathi Govindaraju, MD

Dr. Tirupathi is the Medical Director of Keystone Infectious Diseases/HIV and Keystone Community Health Services in Chambersburg, Pennsylvania. He also serves as the Chair of the Infection Prevention Committees of both WellSpan Chambersburg Hospital and WellSpan Waynesboro Hospital. He has a teaching appointment at the Pennsylvania State College of Medicine in Hershey, Pennsylvania, as Clinical Assistant Professor of Medicine. He serves as the clinical consultant at CURE ID/CURE Drug Repurposing Collaboratory, a joint initiative of the Food and Drug Administration and the National Institutes of Health.

Dr. Tirupathi has many peer-reviewed publications to his credit. His research interests include antimicrobial drug repurposing, infection prevention, antimicrobial stewardship and COVID-19. He has received several honorary fellowships, including from the Infectious Diseases Society of America (IDSA), the Royal College of Physicians and the American College of Physicians. He has also received several prestigious regional and national awards including the Clinical Practice Innovation Award from IDSA.

Dr. Tirupathi completed an internal medicine residency at the Icahn School of Medicine at Mount Sinai/Morristown Medical Center and completed an infectious disease fellowship at the University of Medicine and Dentistry of New Jersey.

As of May 2024, Dr. Tirupathi reported the following ongoing external relationships:

Dr. Tirupathi serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • Pennsylvania Medical Society, Board Member, receiving reimbursement for travel expenses.

Dr. Tirupathi also reported receiving grant funding, including salary support, from the Critical Path Institute CURE Drug Repurposing Collaboratory.